Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases

Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HFSRT) have become important treatment modalities for brain metastases. While effective, there are still areas of extensive debate on its appropriate use in patients with life-limiting diseases. This review provides an o...

Descripción completa

Detalles Bibliográficos
Autores principales: Halasz, Lia M., Rockhill, Jason K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Surgical Neurology International: Neuro-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656557/
https://www.ncbi.nlm.nih.gov/pubmed/23717789
http://dx.doi.org/10.4103/2152-7806.111295
_version_ 1782270026705797120
author Halasz, Lia M.
Rockhill, Jason K.
author_facet Halasz, Lia M.
Rockhill, Jason K.
author_sort Halasz, Lia M.
collection PubMed
description Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HFSRT) have become important treatment modalities for brain metastases. While effective, there are still areas of extensive debate on its appropriate use in patients with life-limiting diseases. This review provides an overview of the indications and challenges of SRS and HFSRT in the management of brain metastases.
format Online
Article
Text
id pubmed-3656557
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36565572013-05-28 Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases Halasz, Lia M. Rockhill, Jason K. Surg Neurol Int Surgical Neurology International: Neuro-Oncology Stereotactic radiosurgery (SRS) and hypofractionated stereotactic radiotherapy (HFSRT) have become important treatment modalities for brain metastases. While effective, there are still areas of extensive debate on its appropriate use in patients with life-limiting diseases. This review provides an overview of the indications and challenges of SRS and HFSRT in the management of brain metastases. Medknow Publications & Media Pvt Ltd 2013-05-02 /pmc/articles/PMC3656557/ /pubmed/23717789 http://dx.doi.org/10.4103/2152-7806.111295 Text en Copyright: © 2013 Halasz LM http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Surgical Neurology International: Neuro-Oncology
Halasz, Lia M.
Rockhill, Jason K.
Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
title Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
title_full Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
title_fullStr Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
title_full_unstemmed Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
title_short Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
title_sort stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
topic Surgical Neurology International: Neuro-Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656557/
https://www.ncbi.nlm.nih.gov/pubmed/23717789
http://dx.doi.org/10.4103/2152-7806.111295
work_keys_str_mv AT halaszliam stereotacticradiosurgeryandstereotacticradiotherapyforbrainmetastases
AT rockhilljasonk stereotacticradiosurgeryandstereotacticradiotherapyforbrainmetastases

Ejemplares similares